PsychiatricTimes Members: Login | Register

|     

PsychiatricTimes SearchMedica Medline Drugs

Powered by SearchMedica

 
Risk Assessment
News
Current Issues
Blogs
Special Reports
CME
Conferences
Resources
Careers
Multimedia
About Us
 

Home » Blogs » Couch in Crisis

Psychiatric Times.
Couch in Crisis 

The Autism “Epidemic” Marches On: What is Driving Rates Even Higher?

By Allen Frances, MD | May 25, 2011

A large and comprehensive study recently performed in Korea has produced a surprising and disturbing result. The rate of autism is reported to be an astounding 1 in 38—almost 3% of the population. Not so very long ago, autism was one of the rarest of disorders, afflicting only 1 child in every 2000 to 5000. Since the publication of DSM-IV in 1994, rates in the United States have exploded to about 1 per 100. The new Korean study adds fuel to widespread fears that some sort of environmental toxin is causing this raging “epidemic.”

No one can know for sure what is going on—how much each of the following 5 possible contributing factors has actually influenced the huge jump in the rate of autism. I will give you my best educated guesses and the rationales supporting them:

•Possible Factor 1: There has been a change in the definition of autism
We know definitely that this is a partial contribution. Before DSM-IV, autism was among the most narrowly and clearly defined of disorders. The symptoms began very early in life, before age 3 years, and were a striking and devastating combination of severe language deficits, inability to form even the rudiments of social relationships, and a preoccupation with a very narrow set of rigid rituals and stereotyped behaviors.

In preparing DSM-IV, we made the decision to add a new category that described a milder (and therefore much more difficult to define and distinguish) form of autism, Asperger Disorder. This seemed necessary because some (still quite rare) children presented with more or less normal language development, but with grave difficulties in making social contact and in engaging flexibly in the expectable range of behaviors. We knew that Asperger was about 3 times more common than classic autism and expected its inclusion to triple the rate of autistic disorders to about 1 per 500 to 1000. That gets us part way up to higher rates, but not nearly to 1 per 38.

•Possible Factor 2: Previously missed cases are now being picked up
An increased awareness of the symptoms of autism and better training in its diagnosis has undoubtedly resulted in improved case finding—thus identifying people who should have been, but previously had not been, diagnosed. It is impossible to determine just how significant a contribution to skyrocketing rates comes from this improved diagnosis. My guess is that this is a factor—but not one that comes close to bringing us from 1:500 to 1:100, much less 1:38.

•Possible Factor 3: An environmental toxin is causing an outbreak of autism
This has been the most popular and most feared explanation. It is almost certainly a quite small factor, if it is a factor at all. There has been no sudden environmental change that would account for such a sudden explosion in rates. The previously most widely accepted contender, Wakefield’s vaccine theory, was proven to be the result of bad and dishonest science. That there is no plausible alternative environmental vector does not disprove the possibility that there might be one, but it certainly makes it quite remote—especially in the face of far more plausible explanations.

•Possible Factor 4: The jump in rates is due to a change in diagnostic habits as autism became an ever more popular fad diagnosis
As the spectrum of autism widened, it came to include people previously considered to be unusually creative, or normally eccentric, or to have a schizoid or schizotypal personality disorder. Autism is no longer seen as a disabling condition and a wide variety of people have discovered their inner autistic self.

Redefined and reinterpreted, autism now casts a wide net catching much milder, everyday problems on the boundary with normality. Once rare and unmistakable, autism is now used loosely to describe people who do not really satisfy the narrow criteria intended by DSM-IV. Widespread publicity, Internet support and advocacy groups, and the fact that expensive school services are provided only for those who are given a diagnosis of autism have occasioned the dramatic swing from false negative to false positive diagnosis. Of interest, an autism advocacy group that could barely contain its enthusiasm at the high rates that were reported financed the Korean study.

•Possible Factor 5: Epidemiological studies always over-report rates
There is a systematic bias in all large-scale epidemiological studies to report as mental disorder even mild presentations of symptoms that may not have any clinical significance. It is entirely plausible that 3% of the population might have a smidgen of autism- completely implausible that so many would have an autistic mental disorder. Rates in epidemiological studies should be seen as no more than a screening upper limit- not a true reflection of the rate of actual mental disorder in the population being studied.

Human nature and the true rates of neurological illness and psychiatric disorder all change very slowly. Environmental toxins are more labile, but generally don’t just pop out of nowhere to make a condition 100x more common than it was just 15 short years ago. By far the most plausible explanations for the autism “epidemic” are factors 1,4, and 5. DSM-IV gave autism purchase by introducing a milder form close to the populous boundary to normality. Then autism took flight on the wings of definitional diffusion, Internet contagion, financial incentive, and naïve interpretation of epidemiological results. The overall rate of autistic symptoms is probably the same as it always has been since time immemorial- only the naming of them has changed.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Addiction Medicine
Alzheimer Disease
Anxiety Disorders
ADHD
Bipolar Disorder
Child & Adolescent Psychiatry
Dementia
Depression
DSM-5
Geriatric Psychiatry

 

Health Care Reform
Major Depressive
Disorder
OCD
Personality Disorders
Schizoaffective Disorder
Schizophrenia
Sleep Disorders
Somatoform Disorders
All Topics

 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Developmental Psychopathology Comes of Age
  • The Moral Struggles of Practicing Psychiatrists
  • Grief and Depression: The Sages Knew the Difference
  • Update on Mental Health Benefits and Substance Use Disorder Services Under the Affordable Care Act
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Synthetic Cathinones: Signs, Symptoms, and Treatment
  • Developmental Psychopathology Comes of Age
  • Psychiatry and the Myth of “Medicalization”
  • An Update on ADHD
  • Successful Aging: Strategies to Help Maintain and Nurture a Healthy Brain
  • Ethical and Legal Issues in Geriatric Psychiatry
  • Eco-Psychiatry: Why We Need to Keep the Environment in Mind
  • DSM-5: Where Do We Go From Here?
  • Suicidal Behavior: A Separate Diagnosis
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • Psychiatry and the Myth of “Medicalization”
  • Grief and Depression: The Sages Knew the Difference
  • Is it Time for a Treatment Manual to Complement DSM-5?
  • Diagnosis and its Discontents: The DSM Debate Continues
  • Lamotrigine for Major Depressive Disorder Is Inappropriate
  • Psychiatry and the Myth of “Medicalization”
  • Parity Laws: Powerful Weapon—or Pipe Dream?
  • The Moral Struggles of Practicing Psychiatrists
  • DSM-5 Won’t Solve the Overdiagnosis Problem—But Clinicians Can
  • NIMH vs DSM 5: No One Wins, Patients Lose
Click here to subscribe to our newsletter


 
CAREER CENTER

  •   Featured Jobs  
  •    Resources   
  • Psychiatry and Nurse Practitioner Opportunities
  • Associate Medical Director - Psychiatrist Delray Beach, Florida
  • Retiring Child Psychiatrist Seeks Replacement August 2010 or Before
  • Chairperson, Dept of Psychiatry Needed
  • FT Staff Psychiatrist - Excellent Benefits
  • BC Adult and Child Psychiatrits - PT and FT Positions Available
  • Managing Risks When Practicing in Three-Party Care Settings
  • 12 Tips for Making Your Practice Greener
  • Keys to Avoiding Malpractice: Standard of Care in Psychiatric Practice
  • Take This Job and Shove It
  • Merging Administrative and Academic Careers in Psychiatry


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy